DMAAR:NASDAQ, Drugs Made In America Acquisition Corp.

Why DMAAR stock rose on November 18

Drugs Made In America Acquisition Corp. rose 11.1% on Wednesday, November 18, 2026, on 215 shares. No headline about DMAAR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

DMAAR stock overview

Drugs Made In America Acquisition Corp. (DMAAR:NASDAQ) closed at $0.125 on November 20, 2026, unchanged on the day. It is trading at its 52-week high of $0.125. Drugs Made In America Acquisition Corp. is part of the Funds & Shells sector.

Key figures

Price
$0.125
Day change
0.00%
Volume
9,101
Average volume
–
Market cap
1M+
52-week range
$0.085 – $0.125
50-day average
–
200-day average
–

Price action over the past year

In 252 trading sessions since November 20, 2025, DMAAR closed higher on 84 days (33%). Its best day was July 21, 2026 (+54.45%) and its worst was March 4, 2026 (-20.10%). The stock moved 10% or more in a single session 43 times. It opened at least 5% above the previous day's high 27 times.

Similar stocks

Find more stocks like DMAAR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.